• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨噬细胞-树突状细胞谱系组织细胞增多症和肿瘤的修订分类

Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.

作者信息

Emile Jean-François, Abla Oussama, Fraitag Sylvie, Horne Annacarin, Haroche Julien, Donadieu Jean, Requena-Caballero Luis, Jordan Michael B, Abdel-Wahab Omar, Allen Carl E, Charlotte Frédéric, Diamond Eli L, Egeler R Maarten, Fischer Alain, Herrera Juana Gil, Henter Jan-Inge, Janku Filip, Merad Miriam, Picarsic Jennifer, Rodriguez-Galindo Carlos, Rollins Barret J, Tazi Abdellatif, Vassallo Robert, Weiss Lawrence M

机构信息

Research Unit EA4340, Versailles University, Paris-Saclay University, Boulogne, France; Pathology Department, Ambroise Paré Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Boulogne, France;

Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada;

出版信息

Blood. 2016 Jun 2;127(22):2672-81. doi: 10.1182/blood-2016-01-690636. Epub 2016 Mar 10.

DOI:10.1182/blood-2016-01-690636
PMID:26966089
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5161007/
Abstract

The histiocytoses are rare disorders characterized by the accumulation of macrophage, dendritic cell, or monocyte-derived cells in various tissues and organs of children and adults. More than 100 different subtypes have been described, with a wide range of clinical manifestations, presentations, and histologies. Since the first classification in 1987, a number of new findings regarding the cellular origins, molecular pathology, and clinical features of histiocytic disorders have been identified. We propose herein a revision of the classification of histiocytoses based on histology, phenotype, molecular alterations, and clinical and imaging characteristics. This revised classification system consists of 5 groups of diseases: (1) Langerhans-related, (2) cutaneous and mucocutaneous, and (3) malignant histiocytoses as well as (4) Rosai-Dorfman disease and (5) hemophagocytic lymphohistiocytosis and macrophage activation syndrome. Herein, we provide guidelines and recommendations for diagnoses of these disorders.

摘要

组织细胞增多症是一类罕见疾病,其特征为巨噬细胞、树突状细胞或单核细胞衍生细胞在儿童和成人的各种组织和器官中蓄积。已描述了100多种不同亚型,临床表现、症状及组织学表现范围广泛。自1987年首次分类以来,已确定了关于组织细胞疾病的细胞起源、分子病理学及临床特征的一些新发现。我们在此基于组织学、表型、分子改变以及临床和影像学特征提出组织细胞增多症分类的修订版。这个修订后的分类系统包括5组疾病:(1) 与朗格汉斯细胞相关的,(2) 皮肤和黏膜皮肤的,(3) 恶性组织细胞增多症以及(4) 罗萨伊-多夫曼病和(5) 噬血细胞性淋巴组织细胞增多症及巨噬细胞活化综合征。在此,我们提供这些疾病诊断的指南和建议。

相似文献

1
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.巨噬细胞-树突状细胞谱系组织细胞增多症和肿瘤的修订分类
Blood. 2016 Jun 2;127(22):2672-81. doi: 10.1182/blood-2016-01-690636. Epub 2016 Mar 10.
2
The Non-Langerhans Cell Histiocytoses (Rare Histiocytoses) - Clinical Aspects and Therapeutic Approaches.非朗格汉斯细胞组织细胞增多症(罕见组织细胞增多症)——临床特征与治疗方法
Klin Padiatr. 2016 Nov;228(6-07):294-306. doi: 10.1055/s-0042-109713. Epub 2016 Nov 15.
3
[Histiocytosis in the dermatological context of the new classification].[新分类下皮肤病学背景中的组织细胞增多症]
Hautarzt. 2019 Sep;70(9):691-699. doi: 10.1007/s00105-019-4460-2.
4
Molecular characterization of the histiocytoses: Neoplasia of dendritic cells and macrophages.组织细胞增多症的分子特征:树突状细胞和巨噬细胞的肿瘤性疾病。
Semin Cell Dev Biol. 2019 Feb;86:62-76. doi: 10.1016/j.semcdb.2018.03.002. Epub 2018 Mar 16.
5
Histiocytosis and Neoplasms of Macrophage-Dendritic Cell Lineages: Multimodality Imaging with Emphasis on PET/CT.组织细胞增生症和巨噬细胞-树突状细胞谱系肿瘤:多模态成像,重点是 PET/CT。
Radiographics. 2021 Mar-Apr;41(2):576-594. doi: 10.1148/rg.2021200096. Epub 2021 Feb 19.
6
[Histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Comparison of recent WHO classification published 2017 and classification of Histiocyte Society published 2016].[巨噬细胞-树突状细胞谱系的组织细胞增生症和肿瘤。2017年发布的世界卫生组织最新分类与2016年组织细胞协会分类的比较]
Vnitr Lek. 2020 Summer;66(6):19-27.
7
[Reactive and neoplastic histiocytic diseases in the dog].[犬的反应性和肿瘤性组织细胞疾病]
Tierarztl Prax Ausg K Kleintiere Heimtiere. 2011;39(3):176-90.
8
The changing landscape of pediatric histiocytoses: Birth, life, and transdifferentiation of pediatric histiocytes.儿科组织细胞增多症的变化格局:儿科组织细胞的诞生、生命和转分化。
Semin Diagn Pathol. 2023 Nov;40(6):420-428. doi: 10.1053/j.semdp.2023.05.003. Epub 2023 May 20.
9
Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society.组织细胞疾病的当代分类。世界卫生组织组织细胞/网状细胞增殖委员会。组织细胞协会重新分类工作组。
Med Pediatr Oncol. 1997 Sep;29(3):157-66. doi: 10.1002/(sici)1096-911x(199709)29:3<157::aid-mpo1>3.0.co;2-c.
10
Histiocytosis - cutaneous manifestations of hematopoietic neoplasm and non-neoplastic histiocytic proliferations.组织细胞增生症 - 造血系统肿瘤和非肿瘤性组织细胞增生的皮肤表现。
J Eur Acad Dermatol Venereol. 2018 Jun;32(6):926-934. doi: 10.1111/jdv.14794. Epub 2018 Jan 31.

引用本文的文献

1
[Pulmonary involvement in rare systemic diseases-part 1 : Pulmonary manifestations in the context of hematological, immunological, histiocytic, and hepatological diseases and chronic inflammatory bowel disease].[罕见系统性疾病中的肺部受累——第1部分:血液学、免疫学、组织细胞病学、肝病学疾病及慢性炎症性肠病背景下的肺部表现]
Radiologie (Heidelb). 2025 Sep 4. doi: 10.1007/s00117-025-01497-z.
2
An intestinal histiocytic sarcoma in a collared peccary (Pecari tajacu): a case report.一只领西猯(Pecari tajacu)的肠道组织细胞肉瘤:病例报告。
Acta Vet Scand. 2025 Sep 2;67(1):43. doi: 10.1186/s13028-025-00828-3.
3
TERT Promoter C228T and C250T Hotspot Mutations Are Absent in BRAF V600E-Positive Langerhans Cell Histiocytosis.BRAF V600E 阳性朗格汉斯细胞组织细胞增多症不存在TERT启动子C228T和C250T热点突变。
Cancer Med. 2025 Aug;14(15):e71115. doi: 10.1002/cam4.71115.
4
Impact of Sex on Lung Function in Adult Langerhans Cell Histiocytosis.性别对成人朗格汉斯细胞组织细胞增多症肺功能的影响
Life (Basel). 2025 Aug 7;15(8):1258. doi: 10.3390/life15081258.
5
Extranodal Rosai-Dorfman Disease in a Pediatric Patient: A Case Report.一名儿科患者的结外Rosai-Dorfman病:病例报告
Am J Case Rep. 2025 Aug 27;26:e948533. doi: 10.12659/AJCR.948533.
6
Langerhans cell sarcoma is a clinically, biologically, and prognostically heterogeneous "malignant" histiocytosis: a systematic review of 88 cases from the literature.朗格汉斯细胞肉瘤是一种在临床、生物学及预后方面具有异质性的“恶性”组织细胞增多症:对文献中88例病例的系统综述
Virchows Arch. 2025 Aug 23. doi: 10.1007/s00428-025-04230-2.
7
[A circuitous route to the diagnosis of a very rare disease].[诊断一种极为罕见疾病的曲折之路]
Inn Med (Heidelb). 2025 Aug 5. doi: 10.1007/s00108-025-01968-4.
8
Cutaneous Limited Langerhans Cell Histiocytosis Complicated by Late-onset Panhypopituitarism.皮肤局限性朗格汉斯细胞组织细胞增多症并发迟发性全垂体功能减退症。
JCEM Case Rep. 2025 Jul 28;3(9):luaf138. doi: 10.1210/jcemcr/luaf138. eCollection 2025 Sep.
9
Isolated osseous Rosai-Dorfman disease: a case report and review of literature.孤立性骨罗萨伊-多夫曼病:一例报告并文献复习
Skeletal Radiol. 2025 Jul 28. doi: 10.1007/s00256-025-04986-3.
10
A case report of cutaneous Langerhans cell Histiocytosis in an infant: a therapeutic challenge.一例婴儿皮肤朗格汉斯细胞组织细胞增多症的病例报告:一项治疗挑战。
Oxf Med Case Reports. 2025 Jul 27;2025(7):omaf112. doi: 10.1093/omcr/omaf112. eCollection 2025 Jul.

本文引用的文献

1
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms.多样且可靶向的激酶改变驱动组织细胞肿瘤。
Cancer Discov. 2016 Feb;6(2):154-65. doi: 10.1158/2159-8290.CD-15-0913. Epub 2015 Nov 13.
2
Nosology and Pathology of Langerhans Cell Histiocytosis.朗格汉斯细胞组织细胞增多症的疾病分类学与病理学
Hematol Oncol Clin North Am. 2015 Oct;29(5):799-823. doi: 10.1016/j.hoc.2015.06.001.
3
ETV3-NCOA2 in indeterminate cell histiocytosis: clonal translocation supports sui generis.ETV3-NCOA2在未定型细胞组织细胞增多症中的作用:克隆易位支持其独特性。
Blood. 2015 Nov 12;126(20):2344-5. doi: 10.1182/blood-2015-07-655530. Epub 2015 Oct 5.
4
Genetic predisposition to hemophagocytic lymphohistiocytosis: Report on 500 patients from the Italian registry.噬血细胞性淋巴组织细胞增生症的遗传易感性:来自意大利登记处的500例患者报告。
J Allergy Clin Immunol. 2016 Jan;137(1):188-196.e4. doi: 10.1016/j.jaci.2015.06.048. Epub 2015 Sep 2.
5
A case report of meningeal Rosai-Dorfman disease associated with IgG4-related disease.一例与IgG4相关疾病相关的脑膜罗萨伊-多夫曼病病例报告。
Clin Neuropathol. 2015 Nov-Dec;34(6):343-9. doi: 10.5414/NP300871.
6
Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations.维莫非尼用于治疗伴有BRAF V600突变的多种非黑色素瘤癌症。
N Engl J Med. 2015 Aug 20;373(8):726-36. doi: 10.1056/NEJMoa1502309.
7
Vemurafenib Use in an Infant for High-Risk Langerhans Cell Histiocytosis.维莫非尼在一名患有高危朗格汉斯细胞组织细胞增多症的婴儿中的应用。
JAMA Oncol. 2015 Sep;1(6):836-8. doi: 10.1001/jamaoncol.2015.0736.
8
The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis.原发性免疫缺陷中的噬血细胞性淋巴组织细胞增生症综合征:对鉴别诊断和发病机制的意义
Haematologica. 2015 Jul;100(7):978-88. doi: 10.3324/haematol.2014.121608. Epub 2015 May 28.
9
MAP2K1 and MAP3K1 mutations in Langerhans cell histiocytosis.朗格汉斯细胞组织细胞增生症中的MAP2K1和MAP3K1突变
Genes Chromosomes Cancer. 2015 Jun;54(6):361-8. doi: 10.1002/gcc.22247. Epub 2015 Mar 31.
10
Common cancer-associated PIK3CA activating mutations rarely occur in Langerhans cell histiocytosis.常见的与癌症相关的PIK3CA激活突变在朗格汉斯细胞组织细胞增多症中很少发生。
Blood. 2015 Apr 9;125(15):2448-9. doi: 10.1182/blood-2015-01-625491.